Deep learning / AI meets biology and chemistry. I am focused on products that accelerate breakthroughs in biological sciences that allow for new products that help peoples lives through huge advancements in health. An example investment we have made is in Freenome.
Not Interested In
Not interested in anything outside of this area. Not interested in digital health that involves behavior modification programs.
George Zachary serves as General Partner at Charles River Ventures. He is also a Board Member of CoTap and Crushpath. Zachary led the Nintendo 64 development business at Silicon Graphics, managed sales and marketing for virtual reality pioneer VPL Research, and served as a product marketer at CATS Software. He is on the board of Stanford SSE, Stanford's StartX and is an advisor to the X PRIZE Foundation. Zachary earned a joint BS from MIT and MIT Sloan.
Mr. Aaron Perman serves as Principal at S3 Ventures. He also served as Chief Executive Officer at Qualia. He is also an Angel Investor. Prior to joining S3, he invested in small-cap publicly traded companies at Western Standard, a long/short equity hedge fund. Earlier in his career, he spent time in the corporate strategy group at Southern California Edison and started a successful small business liquidating computer hardware. He serves as a mentor for the DivInc Accelerator and leads the Emerging Venture Capitalist Association's Austin chapter. He received his BS in International Business from the University of Southern California.
Carl Press serves as Principal at Thoma Bravo. He served as a Senior Associate at HighBAR Partners. Previously, he served at Oaktree Capital Management, where he was an Associate in the Principal Investments Group. While at Oaktree, Press evaluated and executed leveraged buyout, distressed debt-for-control and special situations investments in the technology, energy and financial services sectors. Prior to joining Oaktree, Press was an investment banker with UBS Investment Bank, where he worked on leveraged finance and restructuring assignments for financial sponsors and corporate clients in the technology and industrials sectors. Press has also worked in business development at Addepar, a venture-backed financial software company, where he focused on opportunities in the alternative asset management industry. Additionally, he has held engineering roles at Analog Devices and Motorola. Press holds a BS degree in Electrical Engineering with Honors from the University of Illinois at Urbana-Champaign and an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar. He also serves as the Board Member at Infogix.
Thoma Bravo is a successor to the firm of Golder Thoma & Co. established in 1980. Golder Thoma originated the 'consolidation' or 'buy and build' investment strategy which sought to combine the best of venture investing with the best of leveraged buyouts by investing in a 'platform' business in a fragmented industry, and then working with management to transform it into a larger and more profitable business through internal growth and a series of strategic, industry consolidating acquisitions. Thoma Bravo's strategy has been refined through nine private equity investment funds representing almost $4 billion in committed capital. The firm seeks to invest in established companies that have a history of profitability, earnings (EBITDA) greater than $10 million, and a strong management team with a record of accomplishment. Thoma Bravo's principal focus is on companies headquartered in the U.S., but the firm can invest elsewhere as well. Thoma Bravo's investments can be in the form of take-private transactions, buy-outs, management buy-outs, recapitalizations, roll-overs of a portion of existing equity, and growth equity investments. The firm's usual equity commitment is at least $25 million and can be as large as $200 million or more. Thoma Bravo invests across multiple industries, currently with a particular focus on enterprise and infrastructure software, education, distribution, financial services and consumer goods and services. The firm does not invest in new inventions or technologies, developmental products or services, business start-ups, the biological sciences, motion pictures, distressed businesses, oil and gas or real estate.
Behrman Capital is a private equity investment firm with more than $3.1 billion of capital under management across five funds. Founded in New York in 1991, the firm invests in management buyouts, leveraged buildups and recapitalizations of established growth companies. Target companies typically have revenues ranging from $30 million to $200 million. Behrman's equity investments are generally between $25 million and $100 million. In 1996 the firm expanded with an additional office in San Francisco. Behrman's investments have been focused in five industries: Health Care, Defense, Specialty Manufacturing, Business to Business Outsourcing, and Information Technology.
Any early-stage technology/idea that can have an impact....
Not Interested In
Are you an early stage team with a disruptive idea?
We help founders bring ideas to life.
We can lead Pre-Seed, Seed, and help through a successful A round.
We tend to get more involved in B2B or B2B2C business models and look for
companies in early to early-early stages.... An areas we can add the most value.